Armistice Capital »

Blackline shares owned by Armistice Capital

Quarter-by-quarter ownership of Blackline (BL) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Blackline

Tip: Access up to 7 years of quarterly data

All positions including Blackline held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blackline by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.2M 168k 37.00

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Blackline

BlackRock
Vanguard Group
Clearlake Capital Group
UBS Group
Vanguard Portfolio Management
Fivespan Partners
First Manhattan
Vanguard Capital Management
Neuberger Berman Group
ICONIQ Capital
State Street Corporation
Hawk Ridge Management
Conestoga Capital Advisors
Westwood Holdings
Engaged Capital

View all funds holding Blackline